biomark diagnostics color logo medium
  • Articles and Information

Clinical Trials – Multi Site

Picture of BioMark Diagnostics Inc.
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

BioMark is proud to partner and cooperate with National Cancer Institute in Bangladesh and BioMark China in a phase III multi site trial. The trail will involve over 400 subjects and will focus on 4 cancer indications. All the procedures will follow North American regulatory guidelines that were prepared by Saint Boniface Research centre’s regulatory group.

Share this post:
Categories
Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.
CSE: BUX
OTC: BMKDF
FSE: 20B
More Information
Investors

Related articles ...

biomark-diagnostics-logo-medium2

1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2

Pages
Latest Posts
Site Policies

© 2024 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.

Twitter Linkedin